Author: Denis Pavlovich Sukhachov.
This is a work, and the author’s right to a work under international law comes into force from the moment the work is created.
I am a research doctor. I managed to create a theory for the synthesis of a powerful nootropic.
Here are some more details:
1. Accurate modeling of the SynaptoX-1 molecule
Biochemical structure of the molecule
Formula (preliminary version):
Main nootropic framework: Phenylpiracetam base + Noopeptide fragmentation
Neurotransmitter modulators: Huperzine-A (acetylcholine), L-Tyrosine (dopamine), GABA balance, AMPA modulator (glutamate)
Mitochondrial support: Coenzyme Q10, PQQ, DHA
2. Laboratory synthesis of SynaptoX-1
Required starting reagents
Phenylpiracetam precursor – the base of the molecule.
Noopeptide cyclopropylglycine group – to increase neuroplasticity.
Glutamate modifier – for AMPA receptors.
Acetylcholine derivative – for cholinergic activity.
Mitochondrial complex (CoQ10, PQQ, DHA) – for energy support.
Synthesis procedure (general scheme):
1️⃣ Step 1: Condensation of the phenylpyraacetam backbone with the noopeptide fragment
The amidation reaction using DCC/NHS or CDI is used.
A catalyst (e.g. DIPEA) is required.
2️⃣ Step 2: Addition of an acetylcholine group
A Huperzine-A derivative or a bioactive acetylcholine mimetic is used.
3️⃣ Step 3: Introduction of a glutamate modulator
An approach similar to AMPA-derivatives is used.
4️⃣ Step 4: Final stage – stabilization of the molecule and bioavailability testing
The use of phospholipid encapsulation (to increase permeability through the BBB).
CCN(CC)C(=O)C1=CC=C(C=C1)NCC2=NC3=CC=CC=C3C(=N2)N
As the author, I am the owner of full rights to this development.
My phone number is +380985402438
